Related Experiment Video

Updated: Oct 15, 2025

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.5K

Clinical predictors of nephrotoxicity associated with teicoplanin: Meta-analysis and meta-regression

Toshinori Hirai1, Keiko Hosohata2, Yukari Ogawa3

  • 1Department of Pharmacy, Mie University Hospital, Faculty of Medicine, Mie University, Tsu, Mie, Japan.

Basic & Clinical Pharmacology & Toxicology
|October 29, 2021
PubMed

Insights

This study found that low serum albumin levels increase the risk of teicoplanin-induced nephrotoxicity. Hypoalbuminemia is a key factor in teicoplanin

Area of Science:

  • Pharmacology and Toxicology
  • Infectious Diseases
  • Nephrology

Background:

  • Teicoplanin is a critical glycopeptide antibiotic for treating methicillin-resistant Staphylococcus aureus (MRSA) infections.
  • The clinical factors influencing teicoplanin-associated nephrotoxicity remain incompletely understood.
  • Understanding these factors is crucial for optimizing patient safety and treatment efficacy.

Purpose of the Study:

  • To investigate the relationship between various clinical characteristics and the incidence of nephrotoxicity.
  • To identify specific patient factors that may predict or correlate with teicoplanin-induced kidney damage.
  • To provide evidence-based insights for safer teicoplanin prescribing practices.

Main Methods:

  • A comprehensive meta-analysis of clinical studies published between January 1975 and June 2021.
  • Databases searched included PubMed, Cochrane Library, and Scopus for relevant research on teicoplanin and nephrotoxicity.
  • Meta-regression analysis was employed to evaluate the impact of clinical characteristics on nephrotoxicity outcomes.

Main Results:

  • The overall incidence of teicoplanin-associated nephrotoxicity was 11.0% across eight analyzed studies (634 patients).
  • A trend towards increased nephrotoxicity risk was observed in patients over 65 years old (12.0% vs. 7.0%).
  • Meta-regression revealed a significant negative correlation between serum albumin levels and nephrotoxicity risk (p=0.01).

Conclusions:

  • Hypoalbuminemia is a significant risk factor contributing to teicoplanin-induced nephrotoxicity.
  • Clinical monitoring of serum albumin levels may be essential in patients receiving teicoplanin.
  • Further research should focus on proactive management strategies for patients with hypoalbuminemia to mitigate kidney injury.
Keywords:
albuminhypoalbuminemianephrotoxicityteicoplanin

More Related Videos

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury07:58

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury

Published on: July 17, 2016

9.0K
Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions06:32

Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions

Published on: June 13, 2025

204

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
82
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
29
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
155
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
20
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
202
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
190